medexpress retatrutide 30mg Retatrutide in Southlake, TX |

Select Your Dose Turn the dial to your prescribed dose and confirm it in the display window

New Research Links GLP-1 Agonists to NAION A study published in JAMA Ophthalmology on July 3, 2024, found that type 2 diabetes patients prescribed GLP-1 agonists were at an increased risk for developing a rare and debilitating eye condition called NAION

Cagrilintide monotherapy uses up to 4.5 mg weekly, while retatrutide reaches 12 mg weekly, but combining these maximum doses would almost certainly be unsafe

Understanding the evidence, knowing who should exercise caution, and recognising when to seek medical advice are essential for informed decision-making about GLP-1 therapy